Literature DB >> 20733006

Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion.

Utpal K Mukhopadhyay1, Patrick Mooney, Lilly Jia, Robert Eves, Leda Raptis, Alan S Mak.   

Abstract

We have recently shown that Src induces the formation of podosomes and cell invasion by suppressing endogenous p53, while enhanced p53 strongly represses the Src-induced invasive phenotype. However, the mechanism by which Src and p53 play antagonistic roles in cell invasion is unknown. Here we show that the Stat3 oncogene is a required downstream effector of Src in inducing podosome structures and related invasive phenotypes. Stat3 promotes Src phenotypes through the suppression of p53 and the p53-inducible protein caldesmon, a known podosome antagonist. In contrast, enhanced p53 attenuates Stat3 function and Src-induced podosome formation by upregulating the tumor suppressor PTEN. PTEN, through the inactivation of Src/Stat3 function, also stabilizes the podosome-antagonizing p53/caldesmon axis, thereby further enhancing the anti-invasive potential of the cell. Furthermore, the protein phosphatase activity of PTEN plays a major role in the negative regulation of the Src/Stat3 pathway and represses podosome formation. Our data suggest that cellular invasiveness is dependent on the balance between two opposing forces: the proinvasive oncogenes Src-Stat3 and the anti-invasive tumor suppressors p53-PTEN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733006      PMCID: PMC2953057          DOI: 10.1128/MCB.00004-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

Review 1.  A renaissance for SRC.

Authors:  Timothy J Yeatman
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 2.  Foot and mouth: podosomes, invadopodia and circular dorsal ruffles.

Authors:  Roberto Buccione; James D Orth; Mark A McNiven
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

3.  Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.

Authors:  Myrto Raftopoulou; Sandrine Etienne-Manneville; Annette Self; Sarah Nicholls; Alan Hall
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

4.  Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.

Authors:  Steven J Schreiner; Anthony P Schiavone; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

5.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.

Authors:  Daniel J Freeman; Andrew G Li; Gang Wei; Heng-Hong Li; Nathalie Kertesz; Ralf Lesche; Andrew D Whale; Hilda Martinez-Diaz; Nora Rozengurt; Robert D Cardiff; Xuan Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

Review 6.  Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.

Authors:  Bangyan L Stiles
Journal:  Int J Biochem Cell Biol       Date:  2008-10-02       Impact factor: 5.085

7.  PML is a direct p53 target that modulates p53 effector functions.

Authors:  Elisa de Stanchina; Emmanuelle Querido; Masako Narita; Ramana V Davuluri; Pier Paolo Pandolfi; Gerardo Ferbeyre; Scott W Lowe
Journal:  Mol Cell       Date:  2004-02-27       Impact factor: 17.970

8.  STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells.

Authors:  Guang-hui Li; Hong Wei; Zheng-tang Chen; Sheng-qing Lv; Chang-lin Yin; Dong-lin Wang
Journal:  J Neurooncol       Date:  2008-10-07       Impact factor: 4.130

Review 9.  Invadopodia: at the cutting edge of tumour invasion.

Authors:  Stanley S Stylli; Andrew H Kaye; Peter Lock
Journal:  J Clin Neurosci       Date:  2008-05-12       Impact factor: 1.961

10.  Sequential signals toward podosome formation in NIH-src cells.

Authors:  Tsukasa Oikawa; Toshiki Itoh; Tadaomi Takenawa
Journal:  J Cell Biol       Date:  2008-07-07       Impact factor: 10.539

View more
  26 in total

Review 1.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

2.  Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.

Authors:  Miodrag Dragoj; Jasna Bankovic; Evangelia Sereti; Sofija Jovanovic Stojanov; Konstantinos Dimas; Milica Pesic; Tijana Stankovic
Journal:  Invest New Drugs       Date:  2017-07-22       Impact factor: 3.850

Review 3.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

4.  Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).

Authors:  Yang Jiao; Ke-kang Sun; Lin Zhao; Jia-ying Xu; Li-li Wang; Sai-jun Fan
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

Review 5.  The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function.

Authors:  Danielle A Murphy; Sara A Courtneidge
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-23       Impact factor: 94.444

Review 6.  p53 regulates cytoskeleton remodeling to suppress tumor progression.

Authors:  Keigo Araki; Takahiro Ebata; Alvin Kunyao Guo; Kei Tobiume; Steven John Wolf; Keiko Kawauchi
Journal:  Cell Mol Life Sci       Date:  2015-07-24       Impact factor: 9.261

7.  Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway.

Authors:  Xuyan Chen; Zhiming Huang; Renpin Chen
Journal:  Oncol Lett       Date:  2018-01-24       Impact factor: 2.967

8.  Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

Authors:  Lei-Ya Fang; Kouji Izumi; Kuo-Pao Lai; Liang Liang; Lei Li; Hiroshi Miyamoto; Wen-Jye Lin; Chawnshang Chang
Journal:  Cancer Res       Date:  2013-07-22       Impact factor: 12.701

Review 9.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

10.  IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Authors:  Matjaz Rokavec; Meryem Gülfem Öner; Huihui Li; Rene Jackstadt; Longchang Jiang; Dmitri Lodygin; Markus Kaller; David Horst; Paul K Ziegler; Sarah Schwitalla; Julia Slotta-Huspenina; Franz G Bader; Florian R Greten; Heiko Hermeking
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.